HOME Top Market Reports Apheresis Market by Application (Plasmapheresis, Plateletpheresis, Erythrocytapheresis, Leukapheresis, and Photopheresis), Procedure (Therapeutic Apheresis, Donor Apheresis/Apheresis Blood Donation), Technology & by Product - Global Forecast to 2020

Apheresis Market by Application (Plasmapheresis, Plateletpheresis, Erythrocytapheresis, Leukapheresis, and Photopheresis), Procedure (Therapeutic Apheresis, Donor Apheresis/Apheresis Blood Donation), Technology & by Product - Global Forecast to 2020

By: marketsandmarkets.com
Publishing Date: September 2015
Report Code: MD 1407

Discount on Reports  

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


Apheresis is an essential tool in modern medical practices in the blood industry. It is a process in which the blood of a donor/patient is passed through a medical device, which separates one or more components of the blood and returns the remaining with or without extracorporeal treatment or replacement of separated components.

The global apheresis market is expected to reach USD 2.5 Billion by 2020, growing at a CAGR of 11.2% during the forecast period (2015 to 2020). The market is mainly driven by the rising incidences of blood disorders and chronic diseases, increasing demand for source plasma from biopharmaceutical companies, and increasing demand for blood for transfusion in surgical procedures and accident & trauma cases.

In this report, the apheresis market is segmented by procedure, product, technology, application, and region. The apheresis market, by procedure, is mainly segmented into automated blood collection and therapeutic apheresis. In 2014, the automated blood collection segment accounted for the largest share of approximately 77.2% of the market, and is expected to grow at a CAGR of 10.7% during the forecast period. Growth in this segment is mainly attributed to the increasing severity of blood shortage and growing concern regarding blood safety, and increasing incidences of blood disorders and chronic diseases.

On the basis of applications, the market is segmented into plasmapheresis, plateletpheresis, erythrocytapheresis, leukapheresis, LDL apheresis, and others (photopheresis, lymphapheresis, and extracorporeal immunoadsorption). The plasmapheresis segment accounted for the largest share 46.5% of the global apheresis market in 2014. The large share of plasmapheresis is attributed to the increasing demand of source plasma for transfusion from hospitals and for fractionation from biopharmaceutical companies.

In 2014, North America commanded the largest share of the global market, followed by Europe, Asia-Pacific, Latin America, and the Middle East and Africa. North America accounted for the largest share of 47.8% of global apheresis market in 2014. The U.S. is a prime market due to the easy access to advanced apheresis devices through well-established distribution channels, increased collection of source plasma, and increasing incidences of blood disorders and chronic diseases. On the other hand, Asia-Pacific is the fastest-growing region in the global market, mainly driven by the increasing demand of blood components for the treatment of the large patient population, increased spending capabilities of consumers on healthcare, improving healthcare infrastructure in the region, and increasing investments by leading players and respective government agencies in the region.

Major players in the apheresis market are Haemonetics Corporation (U.S.), Fresenius Medical Care (Germany), Terumo BCT, Inc. (U.S.), Asahi Kasei Medical Co., Ltd. (Japan), Kawasumi Laboratories Inc. (Japan), Cerus Corporation (U.S.), B. Braun Melsungen AG (Germany), HemaCare Corporation (U.S.), Medica S.p.A. (Italy), Kaneka Corporation (Japan), Nikkiso Co., Ltd. (Japan) and Therakos, Inc. (U.S.).

Reasons to Buy the Report

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater market share. Firms purchasing the report could use one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for reaping greater market shares.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the apheresis market. The report analyzes the market by procedure, product, technology, and application across all regions
  • Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and new product launches in the market
  • Market Development: Comprehensive information on the lucrative emerging markets by procedure, product, technology, application, and region
  • Market Diversification: Exhaustive information about new products, growing regions, recent developments, and investments in the apheresis market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, products, distribution networks, manufacturing capabilities, and SWOT analyses of the leading players in the market

Available Customizations for This Report

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of each company

Geographic Analysis

  • Further breakdown of the Rest of Asia-Pacific apheresis market into South Korea, Australia, New Zealand, and others

Company Information

  • Detailed analysis and profiling of additional market players (up to 5)

Table of Contents

1 Introduction (Page No. - 16)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 20)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Key Industry Insights
    2.2 Market Size Estimation
    2.3 Market Breakdown and Data Triangulation
    2.4 Market Share Estimation
    2.5 Assumptions for the Study

3 Executive Summary (Page No. - 27)

4 Premium Insights (Page No. - 32)
    4.1 Growth Potential of the Apheresis Market
    4.2 Asia-Pacific: Apheresis Market, By Application (2014)
    4.3 U.S. Apheresis Market, By Product Type
    4.4 Apheresis Market: Regional Mix
    4.5 Apheresis Market: Developed vs Developing Countries

5 Market Overview (Page No. - 36)
    5.1 Introduction
    5.2 Market Segmentation
           5.2.1 By Product Type
           5.2.2 By Procedure
           5.2.3 By Technology
           5.2.4 By Application
    5.3 Market Dynamics
           5.3.1 Market Drivers
                    5.3.1.1 Rising Prevalence of Various Diseases and Related Increase in Disability Adjusted Life Years (DALYS)
                    5.3.1.2 Increasing Demand for Source Plasma From Biopharmaceutical Companies and Corresponding Increase in Source Plasma Collections
                    5.3.1.3 Severity of Blood Shortage and Growing Concerns Regarding Blood Safety
           5.3.2 Market Restraints
                    5.3.2.1 High Cost of Apheresis Devices and Procedures
                    5.3.2.2 Scarcity of Qualified Donors
           5.3.3 Market Opportunities
                    5.3.3.1 Extending Reach of Apheresis in the Untapped Pediatric Segment
                    5.3.3.2 Emerging Economies With Increasing Investments From Government Bodies and Leading Players
           5.3.4 Market Challenges
                    5.3.4.1 Lack of Awareness and Challenges in Donor Recruitment

6 Industry Insights (Page No. - 47)
    6.1 Introduction
    6.2 Industry Trends
           6.2.1 Growing Number of Agreements and Partnerships
    6.3 Porter’s Five Force Analysis
           6.3.1 Threat of New Entrants
           6.3.2 Threat of Substitutes
           6.3.3 Bargaining Power of Suppliers
           6.3.4 Bargaining Power of Buyers
           6.3.5 Intensity of Competitive Rivalry
    6.4 Regulatory Analysis
           6.4.1 North America
                    6.4.1.1 U.S.
                    6.4.1.2 Canada
           6.4.2 Europe
           6.4.3 Asia-Pacific
                    6.4.3.1 Japan
                    6.4.3.2 China
                    6.4.3.3 India

7 Global Apheresis Market, By Procedure (Page No. - 55)
    7.1 Introduction
    7.2 Automated/Apheresis Blood Collection
    7.3 Therapeutic Apheresis
           7.3.1 Therapeutic Apheresis Market, By Disease
                    7.3.1.1 Neurological Disorders
                    7.3.1.2 Blood Disorders
                    7.3.1.3 Cardiovascular Disorders
                    7.3.1.4 Renal Disorders
                    7.3.1.5 Autoimmune Disorders
                    7.3.1.6 Metabolic Disorders
                    7.3.1.7 Other Disorders
           7.3.2 Therapeutic Apheresis Market, By Procedure
                    7.3.2.1 Therapeutic Plasma Exchange (TPE)
                    7.3.2.2 Therapeutic Cytapheresis
                               7.3.2.2.1 Therapeutic Erythrocytapheresis
                               7.3.2.2.2 Therapeutic Plateletphersis
                               7.3.2.2.3 Leukapheresis
                    7.3.2.3 Photopheresis
                    7.3.2.4 Extracorporeal Immunoadsorption (ECI)
                    7.3.2.5 Low-Density Lipoprotein (LDL) Apheresis

8 Global Apheresis Market, By Product (Page No. - 81)
    8.1 Introduction
    8.2 Devices
    8.3 Disposables

9 Global Apheresis Market, By Technology (Page No. - 88)
    9.1 Introduction
    9.2 Centrifugation
           9.2.1 Intermittent Flow
           9.2.2 Continuous Flow
    9.3 Membrane Separation

10 Global Apheresis Market, By Application (Page No. - 97)
     10.1 Introduction
     10.2 Plasmapheresis
     10.3 Plateletpheresis
     10.4 Erythrocytapheresis
     10.5 Leukapheresis
     10.6 Low Density Lipoprotein (LDL) Apheresis
     10.7 Other Applications

11 Geographic Analysis (Page No. - 108)
     11.1 Introduction
     11.2 North America
             11.2.1 U.S.
             11.2.2 Canada
     11.3 Europe
             11.3.1 Germany
             11.3.2 France
             11.3.3 U.K.
             11.3.4 Italy
             11.3.5 Spain
             11.3.6 Rest of Europe (RoE)
     11.4 Asia-Pacific (APAC)
             11.4.1 Japan
             11.4.2 China
             11.4.3 India
             11.4.4 Rest of Asia-Pacific
     11.5 Latin America
             11.5.1 Brazil
             11.5.2 Mexico
             11.5.3 Rest of Latin America (RoLA)
     11.6 Middle East and Africa

12 Competitive Landscape (Page No. - 150)
     12.1 Overview
     12.2 Market Share Analysis
     12.3 Competitive Situation and Trends
     12.4 Agreements, Partnerships, and Collaborations
     12.5 Mergers and Acquisitions
     12.6 Expansion
     12.7 New Product Launches

13 Company Profiles (Page No. - 158)
     13.1 Introduction
     13.2 Terumo Bct, Inc.
             13.2.1 Business Overview
             13.2.2 Products Offered
             13.2.3 Recent Developments
             13.2.4 MnM View
     13.3 Asahi Kasei Medical Co., Ltd. (A Subsidiary of Asahi Kasei Group)
             13.3.1 Business Overview
             13.3.2 Products Offered
             13.3.3 Recent Developments
             13.3.4 MnM View
     13.4 Fresenius Se & Co. KGAA
             13.4.1 Business Overview
             13.4.2 Products Offered
             13.4.3 Recent Developments
             13.4.4 MnM View
     13.5 Haemonetics Corporation
             13.5.1 Business Overview
             13.5.2 Products Offered
             13.5.3 Recent Developments
             13.5.4 MnM View
     13.6 Cerus Corporation
             13.6.1 Business Overview
             13.6.2 Products Offered
             13.6.3 Recent Developments
             13.6.4 MnM View
     13.7 B. Braun Melsungen AG
             13.7.1 Business Overview
             13.7.2 Products Offered
             13.7.3 Recent Developments
     13.8 Hemacare Corporation
             13.8.1 Business Overview
             13.8.2 Company Snapshot: Hemacare Corporation
             13.8.3 Services Offered
             13.8.4 Recent Developments
     13.9 Medica S.P.A
             13.9.1 Business Overview
             13.9.2 Products Offered
             13.9.3 Recent Developments
     13.10 Kawasumi Laboratories Inc.
             13.10.1 Business Overview
             13.10.2 Products Offered
             13.10.3 Recent Developments
     13.11 Kaneka Corporation
             13.11.1 Business Overview
             13.11.2 Products Offered
             13.11.3 Recent Developments
     13.12 Nikkiso Co., Ltd.
             13.12.1 Business Overview
             13.12.2 Products Offered
             13.12.3 Recent Developments
     13.13 Therakos, Inc.
             13.13.1 Business Overview
             13.13.2 Products Offered
             13.13.3 Recent Developments

14 Appendix (Page No. - 184)
     14.1 Insights of Industry Experts
     14.2 Discussion Guide
     14.3 Other Developments, 2011–2015
     14.4 Introducing RT: Real-Time Market Intelligence
     14.5 Available Customizations
     14.6 Related Reports


List of Tables (139 Tables)

Table 1 Rising Prevalence of Various Diseases and Related Increase in Disability Adjusted Life Years (DALYS) to Drive the Apheresis Market Growth
Table 2 Global Projected DALYS, By Cause, 2008 vs 2015 vs 2030
Table 3 High Cost of Apheresis Devices and Procedures to Restrict Market Growth
Table 4 Frequency of Blood Donations From Healthy Donors
Table 5 Extending Reach of Apheresis in the Untapped Pediatric Segment Offers Significant Opportunities for Apheresis Market
Table 6 Lack of Awareness & Challenges in Donor Recruitment Will Limit the Wider Adoption Among Healthcare Providers and Blood Banks
Table 7 Global Apheresis Market Size, By Procedure, 2013–2020 (USD Million)
Table 8 Global Apheresis Market Size for Automated Blood Collection, By Country, 2013–2020 (USD Million)
Table 9 Global Therapeutic Apheresis Market Size, By Country, 2013–2020 (USD Million)
Table 10 Global Therapeutic Apheresis Market Size, By Disease, 2013–2020 (USD Million)
Table 11 Neurological Diseases/Disorders Treated By Therapeutic Apheresis
Table 12 Global Therapeutic Apheresis Market Size for Neurological Disorders, By Country, 2013–2020 (USD Million)
Table 13 Global Therapeutic Apheresis Market Size for Blood Disorders, By Country, 2013–2020 (USD Million)
Table 14 Global Therapeutic Apheresis Market Size for Cardiovascular Disorders, By Country, 2013–2020 (USD Million)
Table 15 Global Therapeutic Apheresis Market Size for Renal Disorders, By Country, 2013–2020 (USD Million)
Table 16 Global Therapeutic Apheresis Market Size for Autoimmune Disorders, By Country, 2013–2020 (USD Million)
Table 17 Global Therapeutic Apheresis Market Size for Metabolic Disorders, By Country, 2013–2020 (USD Million)
Table 18 Global Therapeutic Apheresis Market Size for Other Disorders, By Country, 2013–2020 (USD Million)
Table 19 Global Therapeutic Apheresis Market Size, By Procedure,  2013–2020 (USD Million)
Table 20 Global Therapeutic Plasma Exchange Market Size, By Country, 2013–2020 (USD Million)
Table 21 Global Therapeutic Cytapheresis Market Size, By Country, 2013–2020 (USD Million)
Table 22 Global Therapeutic Cytapheresis Market Size, By Procedure, 2013–2020 (USD Million)
Table 23 Global Therapeutic Erythrocytapheresis Devices Market Size, By Country, 2013–2020 (USD Million)
Table 24 Global Therapeutic Plateletpheresis Market Size, By Country, 2013–2020 (USD Million)
Table 25 Global Leukapheresis Market Size, By Country, 2013–2020 (USD Million)
Table 26 Global Photopheresis Market Size, By Country, 2013–2020 (USD Million)
Table 27 Global Extracorporeal Immunoadsorption Market Size, By Country, 2013–2020 (USD Million)
Table 28 Global LDL Apheresis Market Size, By Country, 2013–2020 (USD Million)
Table 29 Global Apheresis Market Size, By Product Type, 2013–2020 (USD Million)
Table 30 Apheresis Devices/Systems Available in the Market
Table 31 Global Apheresis Devices Market Size, By Country, 2013–2020 (USD Million)
Table 32 Global Apheresis Disposables Market Size, By Country, 2013–2020 (USD Million)
Table 33 Global Apheresis Market Size, By Technology, 2013–2020 (USD Million)
Table 34 Centrifugation Technology-Based Apheresis Devices
Table 35 Global Centrifugation Market Size, By Country, 2013–2020 (USD Million)
Table 36 Global Centrifugation Market Size, By Type, 2013–2020 (USD Million)
Table 37 Global Intermittent Flow Market Size, By Country, 2013–2020 (USD Million)
Table 38 Global Continuous Flow Market Size, By Country, 2013–2020 (USD Million)
Table 39 Size of Blood Components
Table 40 Membrane Separation Technology-Based Apheresis Devices
Table 41 Global Membrane Separation Market Size, By Country, 2013–2020 (USD Million)
Table 42 Global Apheresis Market Size, By Application, 2013 – 2020 (USD Million)
Table 43 Total Source Plasma Collection in the U.S. & Europe, 2005–2013 (Thousand Liters)
Table 44 Global Apheresis Market Size for Plasmapheresis, By Country, 2013–2020 (USD Million)
Table 45 Global Apheresis Market Size for Plateletpheresis, By Country, 2013–2020 (USD Million)
Table 46 Global  Apheresis Market Size for Erythrocytapheresis, By Country, 2013–2020 (USD Million)
Table 47 Global  Apheresis Market Size for Leukapheresis, By Country, 2013–2020 (USD Million)
Table 48 Global Apheresis Market Size for LDL Apheresis, By Country, 2013–2020 (USD Million)
Table 49 Global Apheresis Market Size for Other Applications, By Country, 2013–2020 (USD Million)
Table 50 Global Apheresis Market Size, By Region, 2013–2020 (USD Million)
Table 51 Global Apheresis Market Size, By Country/Region, 2013–2020 (USD Million)
Table 52 North America: Apheresis Market Size, By Country, 2013–2020 (USD Million)
Table 53 North America: Market Size, By Procedure, 2013–2020 (USD Million)
Table 54 North America: Market Size, By Product Type, 2013–2020 (USD Million)
Table 55 North America: Market Size, By Application, 2013–2020 (USD Million)
Table 56 North America: Market Size, By Technology, 2013–2020 (USD Million)
Table 57 U.S.: Apheresis Market Size, By Procedure, 2013–2020 (USD Million)
Table 58 U.S.: Apheresis Market Size, By Product Type, 2013–2020 (USD Million)
Table 59 U.S.: Apheresis Market Size, By Application, 2013–2020 (USD Million)
Table 60 U.S.: Apheresis Market Size, By Technology, 2013–2020 (USD Million)
Table 61 Canada: Apheresis Market Size, By Procedure, 2013–2020 (USD Million)
Table 62 Canada: Market Size, By Product Type, 2013–2020 (USD Million)
Table 63 Canada: Market Size, By Application, 2013–2020 (USD Million)
Table 64 Canada: Market Size, By Technology, 2013–2020 (USD Million)
Table 65 Europe: Apheresis Market Size, By Country, 2013–2020 (USD Million)
Table 66 Europe: Market Size, By Procedure, 2013–2020 (USD Million)
Table 67 Europe: Market Size, By Product Type, 2013–2020 (USD Million)
Table 68 Europe: Apheresis Market Size, By Application, 2013–2020 (USD Million)
Table 69 Europe: Market Size, By Technology, 2013–2020 (USD Million)
Table 70 Germany: Apheresis Market Size, By Procedure, 2013–2020 (USD Million)
Table 71 Germany: Apheresis Market Size, By Product Type, 2013–2020 (USD Million)
Table 72 Germany:  Market Size, By Application, 2013–2020 (USD Million)
Table 73 Germany:  Market Size, By Technology, 2013–2020 (USD Million)
Table 74 France: Apheresis Market Size, By Procedure, 2013–2020 (USD Million)
Table 75 France: Market Size, By Product Type, 2013–2020 (USD Million)
Table 76 France:  Market Size, By Application, 2013–2020 (USD Million)
Table 77 France: Market Size, By Technology, 2013–2020 (USD Million)
Table 78 U.K.: Apheresis Market Size, By Procedure, 2013–2020 (USD Million)
Table 79 U.K.: Market Size, By Product Type, 2013–2020 (USD Million)
Table 80 U.K.: Apheresis Market Size, By Application, 2013–2020 (USD Million)
Table 81 U.K.: Market Size, By Technology, 2013–2020 (USD Million)
Table 82 Italy: Apheresis Market Size, By Procedure, 2013–2020 (USD Million)
Table 83 Italy: Market Size, By Product Type, 2013–2020 (USD Million)
Table 84 Italy: Market Size, By Application, 2013–2020 (USD Million)
Table 85 Italy: Market Size, By Technology, 2013–2020 (USD Million)
Table 86 Spain: Apheresis Market Size, By Procedure, 2013–2020 (USD Million)
Table 87 Spain: Market Size, By Product Type, 2013–2020 (USD Million)
Table 88 Spain: Apheresis Market Size, By Application, 2013–2020 (USD Million)
Table 89 Spain: Market Size, By Technology, 2013–2020 (USD Million)
Table 90 RoE: Apheresis Market Size, By Procedure, 2013–2020 (USD Million)
Table 91 RoE: Market Size, By Product Type, 2013–2020 (USD Million)
Table 92 RoE: Market Size, By Application, 2013–2020 (USD Million)
Table 93 RoE: Market Size, By Technology, 2013–2020 (USD Million)
Table 94 APAC: Apheresis Market Size, By Country, 2013–2020 (USD Million)
Table 95 APAC: Market Size, By Procedure, 2013–2020 (USD Million)
Table 96 APAC: Apheresis Market Size, By Product Type, 2013–2020 (USD Million)
Table 97 APAC: Market Size, By Application, 2013–2020 (USD Million)
Table 98 APAC: Market Size, By Technology, 2013–2020 (USD Million)
Table 99 Japan: Apheresis Market Size, By Procedure, 2013–2020 (USD Million)
Table 100 Japan: Market Size, By Product Type, 2013–2020 (USD Million)
Table 101 Japan: Market Size, By Application, 2013–2020 (USD Million)
Table 102 Japan: Market Size, By Technology, 2013–2020 (USD Million)
Table 103 China: Apheresis Market Size, By Procedure, 2013–2020 (USD Million)
Table 104 China: Apheresis Market Size, By Product Type, 2013–2020 (USD Million)
Table 105 China: Market Size, By Application, 2013–2020 (USD Million)
Table 106 China: Market Size, By Technology, 2013–2020 (USD Million)
Table 107 India: Apheresis Market Size, By Procedure, 2013–2020 (USD Million)
Table 108 India: Market Size, By Product Type, 2013–2020 (USD Million)
Table 109 India: Market Size, By Application, 2013–2020 (USD Million)
Table 110 India: Market Size, By Technology, 2013–2020 (USD Million)
Table 111 RoAPAC: Apheresis Market Size, By Procedure, 2013–2020 (USD Million)
Table 112 RoAPAC: Market Size, By Product Type, 2013–2020 (USD Million)
Table 113 RoAPAC: Market Size, By Application, 2013–2020 (USD Million)
Table 114 RoAPAC: Market Size, By Technology, 2013–2020 (USD Million)
Table 115 Latin America: Apheresis Market Size, By Country, 2013–2020 (USD Million)
Table 116 Latin America: Market Size, By Procedure, 2013–2020 (USD Million)
Table 117 Latin America: Apheresis Market Size, By Product Type, 2013–2020 (USD Million)
Table 118 Latin America: Market Size, By Application, 2013–2020 (USD Million)
Table 119 Latin America: Market Size, By Technology, 2013–2020 (USD Million)
Table 120 Brazil: Apheresis Market Size, By Procedure, 2013–2020 (USD Million)
Table 121 Brazil: Market Size, By Product Type, 2013–2020 (USD Million)
Table 122 Brazil: Market Size, By Application, 2013–2020 (USD Million)
Table 123 Brazil: Market Size, By Technology, 2013–2020 (USD Million)
Table 124 Mexico: Apheresis Market Size, By Procedure, 2013–2020 (USD Million)
Table 125 Mexico: Market Size, By Product Type, 2013–2020 (USD Million)
Table 126 Mexico: Apheresis Market Size, By Application, 2013–2020 (USD Million)
Table 127 Mexico: Market Size, By Technology, 2013–2020 (USD Million)
Table 128 RoLA: Apheresis Market Size, By Procedure, 2013–2020 (USD Million)
Table 129 RoLA: Market Size, By Product Type, 2013–2020 (USD Million)
Table 130 RoLA: Apheresis Market Size, By Application, 2013–2020 (USD Million)
Table 131 RoLA: Market Size, By Technology, 2013–2020 (USD Million)
Table 132 Middle East and Africa: Apheresis Market Size, By Procedure, 2013–2020 (USD Million)
Table 133 Middle East and Africa: Market Size, By Product Type, 2013–2020 (USD Million)
Table 134 Middle East and Africa: Market Size, By Application, 2013–2020 (USD Million)
Table 135 Middle East and Africa: Market Size, By Technology, 2013–2020 (USD Million)
Table 136 Agreements, Partnerships, and Collaborations, 2011–2015
Table 137 Mergers and Acquisitions, 2011–2015
Table 138 Expansions, 2011–2015
Table 139 New Product Launches, 2011–2015


List of Figures (45 Figures)

Figure 1 Global Apheresis Market
Figure 2 Research Design
Figure 3 Bottom-Up Approach
Figure 4 Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Global Apheresis Market Size, By Procedure, 2015 vs 2020 (USD Million)
Figure 7 Global Apheresis Market Size, By Product, 2015 vs 2020 (USD Million)
Figure 8 Global Apheresis Market Size, By Application, 2015 vs 2020 (USD Million)
Figure 9 Global Apheresis Market Size, By Technology, 2015 vs 2020 (USD Million)
Figure 10 Geographic Snapshot
Figure 11 Apheresis Market Share Analysis (2014)
Figure 12 Rising Prevalence and Incidences of Chronic Diseases to Drive the Market Growth
Figure 13 Plasmapheresis Accounted for the Largest Share of the Asia-Pacific Apheresis Market
Figure 14 Disposables to Command Largest Share in the U.S. Apheresis Market
Figure 15 North America to Dominate the Apheresis Market During the Forecast Period
Figure 16 Developing Markets to Register Higher Growth During the Forecast Period
Figure 17 Market Segmentation, By Product Type
Figure 18 Market Segmentation, By Procedure
Figure 19 Market Segmentation, By Technology
Figure 20 Market Segmentation, By Application
Figure 21 Market: Drivers, Restraints, Opportunities, & Challenges
Figure 22 Type of Plasma Processed Worldwide, 1996–2012 (Thousand Liters)
Figure 23 Source Plasma Collections in the U.S. & Europe, 2005–2013 (Thousand Liters)
Figure 24 Porter’s Five Forces Analysis: Apheresis Market
Figure 25 Therapeutic Apheresis is the Fastest-Growing Segment of the Apheresis Procedures Market
Figure 26 Disposables are the Fastest-Growing Segment in the Apheresis Products Market
Figure 27 Centrifugation Technology Segment to Grow at the Highest CAGR During the Forecast Period
Figure 28 Others Applications (Photopheresis, Lipidpheresis, Lymphapheresis, and Immunoadsorption) is the Fastest-Growing Segment in the Apheresis Market
Figure 29 North America to Dominate the Apheresis Market During the Forecast Period
Figure 30 North American Apheresis Market Overview
Figure 31 Europe: Market Overview
Figure 32 Agreements/Collaborations/Partnerships Were the Most-Preferred Strategies Between 2011 and 2015
Figure 33 Global Market Share Analysis, By Key Player, 2014
Figure 34 Battle for Market Share: Agreements/Collaborations/Partnerships, the Key Strategies
Figure 35 Geographic Revenue Mix of Major Players
Figure 36 Company Snapshot: Terumo Corporation
Figure 37 Company Snapshot: Asahi Kasei Group
Figure 38 Company Snapshot: Fresenius Medical Care
Figure 39 Company Snapshot: Fresenius Kabi
Figure 40 Company Snapshot: Haemonetics Corporation
Figure 41 Company Snapshot: Cerus Corporation
Figure 42 Company Snapshot: B. Braun Melsungen AG
Figure 43 Company Snapshot: Kawasumi Laboratories Inc.
Figure 44 Company Snapshot: Kaneka Corporation
Figure 45 Company Snapshot: Nikkiso Co., Ltd.

The global apheresis market is estimated to reach USD 2.5 Billion by 2020, growing at a CAGR of 11.2% during the forecast period (2015 to 2020). This market is mainly driven by the increasing severity of blood shortage and growing concerns regarding blood safety, rapid growth in aging population, increasing number of surgical procedures and emergency treatment cases in hospitals, and increasing demand for source plasma from biopharmaceutical companies, worldwide. Extending reach of therapeutic apheresis in the global market and the application of therapeutic apheresis for pediatric treatment are expected to offer significant growth opportunities for the market in the coming years. However, factors such as high cost of apheresis procedures, lack of awareness about the apheresis process, and challenges in donor recruitment are restraining the growth of the apheresis market.

In this report, the apheresis market is segmented on the basis of product, procedure, technology, application, and region. The research report discusses the key market drivers, restraints, opportunities, and challenges in the global apheresis market and its submarkets.

On the basis of product, the market is segmented into devices and disposables. In 2014, the disposables segment accounted for the largest share­ 85.1% of the global market, and this segment is poised to grow at a CAGR of 11.6% during the forecast period. Growth in this market is attributed to the increasing demand for disposables with the increasing number of therapeutic apheresis procedures, and increasing trend towards apheresis blood collections.

On the basis of application, the market is segmented into plasmapheresis, plateletpheresis, erythrocytapheresis, leukapheresis, LDL apheresis, and others (photopheresis, lymphapheresis, and extracorporeal immunoadsorption). The plasmapheresis segment accounted for the largest share 46.5% of the global apheresis market in 2014. The large share of this segment is attributed to the increasing demand of source plasma for transfusion from hospitals and for fractionation from biopharmaceutical companies.

In this report, the global apheresis market is studied at regional and country levels. In 2014, North America commanded the largest share of the apheresis market, and this region is poised to continue to dominate the market during the forecast period. However, the Asia-Pacific region is expected to be the fastest-growing regional market in the coming years. Growth in this region is attributed to the increasing demand of blood components for transfusion from increasing surgical procedures and accidents & trauma cases, rapid development in the healthcare infrastructure, and increasing per capita income of the middle class population in the region.

Major players in the global apheresis market are Haemonetics Corporation (U.S.), Fresenius Medical Care (Germany), Terumo BCT, Inc. (U.S.), Asahi Kasei Medical Co., Ltd. (Japan), Kawasumi Laboratories Inc. (Japan), Cerus Corporation (U.S.), B. Braun Melsungen AG (Germany), HemaCare Corporation (U.S.), Medica S.p.A. (Italy), Kaneka Corporation (Japan), Nikkiso Co., Ltd. (Japan), and Therakos, Inc. (U.S.).

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Therapeutic Markets on KnowledgeStore
Request Demo